EA009362B1 - Терапевтическая пена - Google Patents
Терапевтическая пена Download PDFInfo
- Publication number
- EA009362B1 EA009362B1 EA200600985A EA200600985A EA009362B1 EA 009362 B1 EA009362 B1 EA 009362B1 EA 200600985 A EA200600985 A EA 200600985A EA 200600985 A EA200600985 A EA 200600985A EA 009362 B1 EA009362 B1 EA 009362B1
- Authority
- EA
- Eurasian Patent Office
- Prior art keywords
- foam
- gas
- cylinder
- nitrogen
- oxygen
- Prior art date
Links
- 239000006260 foam Substances 0.000 title claims abstract description 410
- 230000001225 therapeutic effect Effects 0.000 title claims abstract description 8
- 239000007789 gas Substances 0.000 claims abstract description 340
- IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 claims abstract description 259
- CURLTUGMZLYLDI-UHFFFAOYSA-N Carbon dioxide Chemical compound O=C=O CURLTUGMZLYLDI-UHFFFAOYSA-N 0.000 claims abstract description 190
- 238000000034 method Methods 0.000 claims abstract description 155
- 239000007788 liquid Substances 0.000 claims abstract description 143
- 229910052760 oxygen Inorganic materials 0.000 claims abstract description 124
- 229910052757 nitrogen Inorganic materials 0.000 claims abstract description 123
- 239000001301 oxygen Substances 0.000 claims abstract description 120
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 claims abstract description 119
- 229910002092 carbon dioxide Inorganic materials 0.000 claims abstract description 95
- 239000000203 mixture Substances 0.000 claims abstract description 95
- 239000001569 carbon dioxide Substances 0.000 claims abstract description 84
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 claims description 197
- 239000003229 sclerosing agent Substances 0.000 claims description 42
- 238000005187 foaming Methods 0.000 claims description 36
- 239000012071 phase Substances 0.000 claims description 26
- 239000007791 liquid phase Substances 0.000 claims description 22
- 239000012298 atmosphere Substances 0.000 claims description 20
- 239000000463 material Substances 0.000 claims description 20
- 238000002347 injection Methods 0.000 claims description 17
- 239000007924 injection Substances 0.000 claims description 17
- 229910001873 dinitrogen Inorganic materials 0.000 claims description 14
- 238000004519 manufacturing process Methods 0.000 claims description 11
- 210000003752 saphenous vein Anatomy 0.000 claims description 10
- 239000012528 membrane Substances 0.000 claims description 9
- UBAZGMLMVVQSCD-UHFFFAOYSA-N carbon dioxide;molecular oxygen Chemical compound O=O.O=C=O UBAZGMLMVVQSCD-UHFFFAOYSA-N 0.000 claims description 6
- 238000011109 contamination Methods 0.000 claims description 5
- 229960000776 sodium tetradecyl sulfate Drugs 0.000 claims description 3
- UPUIQOIQVMNQAP-UHFFFAOYSA-M sodium;tetradecyl sulfate Chemical compound [Na+].CCCCCCCCCCCCCCOS([O-])(=O)=O UPUIQOIQVMNQAP-UHFFFAOYSA-M 0.000 claims description 2
- 229920001363 Polidocanol Polymers 0.000 claims 1
- 229960002226 polidocanol Drugs 0.000 claims 1
- ONJQDTZCDSESIW-UHFFFAOYSA-N polidocanol Chemical compound CCCCCCCCCCCCOCCOCCOCCOCCOCCOCCOCCOCCOCCO ONJQDTZCDSESIW-UHFFFAOYSA-N 0.000 claims 1
- 239000000243 solution Substances 0.000 abstract description 90
- 206010046996 Varicose vein Diseases 0.000 abstract description 18
- 208000027185 varicose disease Diseases 0.000 abstract description 15
- 239000008152 sclerosing solution Substances 0.000 abstract description 3
- 239000003570 air Substances 0.000 description 72
- 235000011187 glycerol Nutrition 0.000 description 68
- 239000008280 blood Substances 0.000 description 65
- 210000004369 blood Anatomy 0.000 description 65
- 239000012535 impurity Substances 0.000 description 38
- 239000012530 fluid Substances 0.000 description 31
- 238000002156 mixing Methods 0.000 description 30
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 30
- 229910002091 carbon monoxide Inorganic materials 0.000 description 28
- 230000000694 effects Effects 0.000 description 25
- 230000001965 increasing effect Effects 0.000 description 25
- 238000012360 testing method Methods 0.000 description 25
- 239000011521 glass Substances 0.000 description 22
- 210000003462 vein Anatomy 0.000 description 22
- 238000002474 experimental method Methods 0.000 description 21
- 238000007632 sclerotherapy Methods 0.000 description 21
- 239000003708 ampul Substances 0.000 description 20
- 238000007654 immersion Methods 0.000 description 20
- 239000011148 porous material Substances 0.000 description 19
- 238000002360 preparation method Methods 0.000 description 19
- 239000000443 aerosol Substances 0.000 description 18
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 17
- 210000004204 blood vessel Anatomy 0.000 description 17
- 230000007246 mechanism Effects 0.000 description 15
- 239000003795 chemical substances by application Substances 0.000 description 14
- 238000011049 filling Methods 0.000 description 14
- 238000009826 distribution Methods 0.000 description 13
- 230000036961 partial effect Effects 0.000 description 13
- 229920000036 polyvinylpyrrolidone Polymers 0.000 description 13
- 235000013855 polyvinylpyrrolidone Nutrition 0.000 description 13
- 239000001267 polyvinylpyrrolidone Substances 0.000 description 13
- GQPLMRYTRLFLPF-UHFFFAOYSA-N Nitrous Oxide Chemical compound [O-][N+]#N GQPLMRYTRLFLPF-UHFFFAOYSA-N 0.000 description 12
- 230000003993 interaction Effects 0.000 description 12
- 239000002245 particle Substances 0.000 description 11
- 238000002560 therapeutic procedure Methods 0.000 description 11
- 239000007853 buffer solution Substances 0.000 description 10
- -1 for example Substances 0.000 description 10
- 230000008859 change Effects 0.000 description 9
- 235000019441 ethanol Nutrition 0.000 description 9
- 230000008569 process Effects 0.000 description 9
- 238000013461 design Methods 0.000 description 8
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 7
- 229910052782 aluminium Inorganic materials 0.000 description 7
- XAGFODPZIPBFFR-UHFFFAOYSA-N aluminium Chemical compound [Al] XAGFODPZIPBFFR-UHFFFAOYSA-N 0.000 description 7
- 238000007789 sealing Methods 0.000 description 7
- 239000000126 substance Substances 0.000 description 7
- 239000000725 suspension Substances 0.000 description 7
- 238000012546 transfer Methods 0.000 description 7
- XKRFYHLGVUSROY-UHFFFAOYSA-N Argon Chemical compound [Ar] XKRFYHLGVUSROY-UHFFFAOYSA-N 0.000 description 6
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 description 6
- 230000008901 benefit Effects 0.000 description 6
- 230000015572 biosynthetic process Effects 0.000 description 6
- 238000004090 dissolution Methods 0.000 description 6
- 239000001272 nitrous oxide Substances 0.000 description 6
- 229920003023 plastic Polymers 0.000 description 6
- 239000004033 plastic Substances 0.000 description 6
- 238000005086 pumping Methods 0.000 description 6
- 238000010926 purge Methods 0.000 description 6
- 239000011780 sodium chloride Substances 0.000 description 6
- 238000003860 storage Methods 0.000 description 6
- MYMOFIZGZYHOMD-UHFFFAOYSA-N Dioxygen Chemical compound O=O MYMOFIZGZYHOMD-UHFFFAOYSA-N 0.000 description 5
- 229920003082 Povidone K 90 Polymers 0.000 description 5
- 230000007423 decrease Effects 0.000 description 5
- 238000011160 research Methods 0.000 description 5
- 210000001519 tissue Anatomy 0.000 description 5
- 239000004743 Polypropylene Substances 0.000 description 4
- 238000004458 analytical method Methods 0.000 description 4
- 238000011161 development Methods 0.000 description 4
- 239000003814 drug Substances 0.000 description 4
- 238000009434 installation Methods 0.000 description 4
- 239000004620 low density foam Substances 0.000 description 4
- 238000004806 packaging method and process Methods 0.000 description 4
- 229920001155 polypropylene Polymers 0.000 description 4
- 238000003825 pressing Methods 0.000 description 4
- 210000001147 pulmonary artery Anatomy 0.000 description 4
- 230000002829 reductive effect Effects 0.000 description 4
- 229910052717 sulfur Inorganic materials 0.000 description 4
- 238000002604 ultrasonography Methods 0.000 description 4
- 239000004677 Nylon Substances 0.000 description 3
- 230000009471 action Effects 0.000 description 3
- 229910052786 argon Inorganic materials 0.000 description 3
- 230000000712 assembly Effects 0.000 description 3
- 238000000429 assembly Methods 0.000 description 3
- 238000005266 casting Methods 0.000 description 3
- 239000013256 coordination polymer Substances 0.000 description 3
- 238000009792 diffusion process Methods 0.000 description 3
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 3
- 208000035475 disorder Diseases 0.000 description 3
- 238000006073 displacement reaction Methods 0.000 description 3
- 239000012153 distilled water Substances 0.000 description 3
- 239000004744 fabric Substances 0.000 description 3
- 239000000835 fiber Substances 0.000 description 3
- 239000001307 helium Substances 0.000 description 3
- 229910052734 helium Inorganic materials 0.000 description 3
- SWQJXJOGLNCZEY-UHFFFAOYSA-N helium atom Chemical compound [He] SWQJXJOGLNCZEY-UHFFFAOYSA-N 0.000 description 3
- 230000001976 improved effect Effects 0.000 description 3
- 239000004615 ingredient Substances 0.000 description 3
- 230000033001 locomotion Effects 0.000 description 3
- 238000005259 measurement Methods 0.000 description 3
- 229910052754 neon Inorganic materials 0.000 description 3
- GKAOGPIIYCISHV-UHFFFAOYSA-N neon atom Chemical compound [Ne] GKAOGPIIYCISHV-UHFFFAOYSA-N 0.000 description 3
- 229920001778 nylon Polymers 0.000 description 3
- 230000000704 physical effect Effects 0.000 description 3
- 229920001343 polytetrafluoroethylene Polymers 0.000 description 3
- 239000004810 polytetrafluoroethylene Substances 0.000 description 3
- 239000002904 solvent Substances 0.000 description 3
- 201000009371 venous hemangioma Diseases 0.000 description 3
- 229910052724 xenon Inorganic materials 0.000 description 3
- FHNFHKCVQCLJFQ-UHFFFAOYSA-N xenon atom Chemical compound [Xe] FHNFHKCVQCLJFQ-UHFFFAOYSA-N 0.000 description 3
- 206010001526 Air embolism Diseases 0.000 description 2
- 206010008479 Chest Pain Diseases 0.000 description 2
- 241000867077 Macropes Species 0.000 description 2
- 239000004698 Polyethylene Substances 0.000 description 2
- 238000010521 absorption reaction Methods 0.000 description 2
- 230000017531 blood circulation Effects 0.000 description 2
- 238000004140 cleaning Methods 0.000 description 2
- 238000010276 construction Methods 0.000 description 2
- 230000007797 corrosion Effects 0.000 description 2
- 238000005260 corrosion Methods 0.000 description 2
- 230000001186 cumulative effect Effects 0.000 description 2
- 230000006378 damage Effects 0.000 description 2
- 230000008021 deposition Effects 0.000 description 2
- 238000007599 discharging Methods 0.000 description 2
- 229940079593 drug Drugs 0.000 description 2
- 210000003038 endothelium Anatomy 0.000 description 2
- 239000000945 filler Substances 0.000 description 2
- 238000009472 formulation Methods 0.000 description 2
- 238000004817 gas chromatography Methods 0.000 description 2
- 229920001903 high density polyethylene Polymers 0.000 description 2
- 239000004700 high-density polyethylene Substances 0.000 description 2
- 230000006872 improvement Effects 0.000 description 2
- 239000011261 inert gas Substances 0.000 description 2
- 230000036512 infertility Effects 0.000 description 2
- 238000001990 intravenous administration Methods 0.000 description 2
- 239000002648 laminated material Substances 0.000 description 2
- 239000002650 laminated plastic Substances 0.000 description 2
- 229910052751 metal Inorganic materials 0.000 description 2
- 239000002184 metal Substances 0.000 description 2
- 238000012986 modification Methods 0.000 description 2
- 230000004048 modification Effects 0.000 description 2
- 229910000402 monopotassium phosphate Inorganic materials 0.000 description 2
- 235000019796 monopotassium phosphate Nutrition 0.000 description 2
- 230000035515 penetration Effects 0.000 description 2
- PJNZPQUBCPKICU-UHFFFAOYSA-N phosphoric acid;potassium Chemical compound [K].OP(O)(O)=O PJNZPQUBCPKICU-UHFFFAOYSA-N 0.000 description 2
- 229920000573 polyethylene Polymers 0.000 description 2
- 230000001105 regulatory effect Effects 0.000 description 2
- 238000012216 screening Methods 0.000 description 2
- 238000000926 separation method Methods 0.000 description 2
- 125000006850 spacer group Chemical group 0.000 description 2
- 239000003381 stabilizer Substances 0.000 description 2
- 238000010561 standard procedure Methods 0.000 description 2
- 230000002792 vascular Effects 0.000 description 2
- 125000000391 vinyl group Chemical group [H]C([*])=C([H])[H] 0.000 description 2
- 229920002554 vinyl polymer Polymers 0.000 description 2
- 239000002699 waste material Substances 0.000 description 2
- 206010002091 Anaesthesia Diseases 0.000 description 1
- 241000894006 Bacteria Species 0.000 description 1
- 241000195940 Bryophyta Species 0.000 description 1
- 206010011951 Decompression Sickness Diseases 0.000 description 1
- VEXZGXHMUGYJMC-DYCDLGHISA-N Deuterium chloride Chemical compound [2H]Cl VEXZGXHMUGYJMC-DYCDLGHISA-N 0.000 description 1
- 206010014513 Embolism arterial Diseases 0.000 description 1
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 1
- 102000001554 Hemoglobins Human genes 0.000 description 1
- 108010054147 Hemoglobins Proteins 0.000 description 1
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 description 1
- 206010061218 Inflammation Diseases 0.000 description 1
- 241001465754 Metazoa Species 0.000 description 1
- DMUAPQTXSSNEDD-QALJCMCCSA-N Midecamycin Chemical compound C1[C@](O)(C)[C@@H](OC(=O)CC)[C@H](C)O[C@H]1O[C@H]1[C@H](N(C)C)[C@@H](O)[C@H](O[C@@H]2[C@H]([C@H](OC(=O)CC)CC(=O)O[C@H](C)C/C=C/C=C/[C@H](O)[C@H](C)C[C@@H]2CC=O)OC)O[C@@H]1C DMUAPQTXSSNEDD-QALJCMCCSA-N 0.000 description 1
- 101100518501 Mus musculus Spp1 gene Proteins 0.000 description 1
- 229920002302 Nylon 6,6 Polymers 0.000 description 1
- 229920001213 Polysorbate 20 Polymers 0.000 description 1
- 102100040678 Programmed cell death protein 1 Human genes 0.000 description 1
- 101710089372 Programmed cell death protein 1 Proteins 0.000 description 1
- 208000034189 Sclerosis Diseases 0.000 description 1
- 208000009443 Vascular Malformations Diseases 0.000 description 1
- 206010047571 Visual impairment Diseases 0.000 description 1
- 230000002159 abnormal effect Effects 0.000 description 1
- 230000003213 activating effect Effects 0.000 description 1
- 239000000654 additive Substances 0.000 description 1
- 230000000996 additive effect Effects 0.000 description 1
- 239000002390 adhesive tape Substances 0.000 description 1
- 150000001298 alcohols Chemical class 0.000 description 1
- 125000000217 alkyl group Chemical group 0.000 description 1
- 239000012080 ambient air Substances 0.000 description 1
- 230000037005 anaesthesia Effects 0.000 description 1
- 239000008365 aqueous carrier Substances 0.000 description 1
- 210000003157 atrial septum Anatomy 0.000 description 1
- 230000004888 barrier function Effects 0.000 description 1
- WQZGKKKJIJFFOK-VFUOTHLCSA-N beta-D-glucose Chemical compound OC[C@H]1O[C@@H](O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-VFUOTHLCSA-N 0.000 description 1
- 230000005540 biological transmission Effects 0.000 description 1
- 210000004556 brain Anatomy 0.000 description 1
- 239000000872 buffer Substances 0.000 description 1
- 238000001354 calcination Methods 0.000 description 1
- 238000004422 calculation algorithm Methods 0.000 description 1
- 238000004364 calculation method Methods 0.000 description 1
- 229910052799 carbon Inorganic materials 0.000 description 1
- 230000015556 catabolic process Effects 0.000 description 1
- 210000004027 cell Anatomy 0.000 description 1
- 230000004087 circulation Effects 0.000 description 1
- 238000004891 communication Methods 0.000 description 1
- 230000000052 comparative effect Effects 0.000 description 1
- 230000000295 complement effect Effects 0.000 description 1
- 230000006835 compression Effects 0.000 description 1
- 238000007906 compression Methods 0.000 description 1
- 238000000748 compression moulding Methods 0.000 description 1
- 238000004590 computer program Methods 0.000 description 1
- 239000000470 constituent Substances 0.000 description 1
- 239000000356 contaminant Substances 0.000 description 1
- 238000007796 conventional method Methods 0.000 description 1
- 238000001816 cooling Methods 0.000 description 1
- 230000008878 coupling Effects 0.000 description 1
- 238000010168 coupling process Methods 0.000 description 1
- 238000005859 coupling reaction Methods 0.000 description 1
- 238000002788 crimping Methods 0.000 description 1
- 125000004122 cyclic group Chemical group 0.000 description 1
- 230000003247 decreasing effect Effects 0.000 description 1
- 230000007547 defect Effects 0.000 description 1
- 238000006731 degradation reaction Methods 0.000 description 1
- 238000001514 detection method Methods 0.000 description 1
- 238000010586 diagram Methods 0.000 description 1
- 238000010790 dilution Methods 0.000 description 1
- 239000012895 dilution Substances 0.000 description 1
- LOKCTEFSRHRXRJ-UHFFFAOYSA-I dipotassium trisodium dihydrogen phosphate hydrogen phosphate dichloride Chemical compound P(=O)(O)(O)[O-].[K+].P(=O)(O)([O-])[O-].[Na+].[Na+].[Cl-].[K+].[Cl-].[Na+] LOKCTEFSRHRXRJ-UHFFFAOYSA-I 0.000 description 1
- KDQPSPMLNJTZAL-UHFFFAOYSA-L disodium hydrogenphosphate dihydrate Chemical compound O.O.[Na+].[Na+].OP([O-])([O-])=O KDQPSPMLNJTZAL-UHFFFAOYSA-L 0.000 description 1
- 230000009189 diving Effects 0.000 description 1
- 238000005553 drilling Methods 0.000 description 1
- 238000001035 drying Methods 0.000 description 1
- 238000010981 drying operation Methods 0.000 description 1
- 230000008030 elimination Effects 0.000 description 1
- 238000003379 elimination reaction Methods 0.000 description 1
- 238000005516 engineering process Methods 0.000 description 1
- 230000002708 enhancing effect Effects 0.000 description 1
- 230000007613 environmental effect Effects 0.000 description 1
- 239000003822 epoxy resin Substances 0.000 description 1
- 150000002148 esters Chemical class 0.000 description 1
- 230000007717 exclusion Effects 0.000 description 1
- 230000002349 favourable effect Effects 0.000 description 1
- 210000000497 foam cell Anatomy 0.000 description 1
- 239000004872 foam stabilizing agent Substances 0.000 description 1
- 239000011888 foil Substances 0.000 description 1
- 239000007792 gaseous phase Substances 0.000 description 1
- 239000008103 glucose Substances 0.000 description 1
- 150000002303 glucose derivatives Chemical class 0.000 description 1
- 210000003709 heart valve Anatomy 0.000 description 1
- 230000004054 inflammatory process Effects 0.000 description 1
- LTINPJMVDKPJJI-UHFFFAOYSA-N iodinated glycerol Chemical compound CC(I)C1OCC(CO)O1 LTINPJMVDKPJJI-UHFFFAOYSA-N 0.000 description 1
- 210000005246 left atrium Anatomy 0.000 description 1
- 210000005240 left ventricle Anatomy 0.000 description 1
- 239000008263 liquid aerosol Substances 0.000 description 1
- 230000014759 maintenance of location Effects 0.000 description 1
- QSHDDOUJBYECFT-UHFFFAOYSA-N mercury Chemical compound [Hg] QSHDDOUJBYECFT-UHFFFAOYSA-N 0.000 description 1
- 229910052753 mercury Inorganic materials 0.000 description 1
- 230000007576 microinfarct Effects 0.000 description 1
- 238000012544 monitoring process Methods 0.000 description 1
- 238000000465 moulding Methods 0.000 description 1
- 235000011929 mousse Nutrition 0.000 description 1
- 230000002107 myocardial effect Effects 0.000 description 1
- 208000010125 myocardial infarction Diseases 0.000 description 1
- 150000002829 nitrogen Chemical class 0.000 description 1
- 231100001079 no serious adverse effect Toxicity 0.000 description 1
- 238000012148 non-surgical treatment Methods 0.000 description 1
- 230000003287 optical effect Effects 0.000 description 1
- 230000001590 oxidative effect Effects 0.000 description 1
- 125000005429 oxyalkyl group Chemical group 0.000 description 1
- 238000010979 pH adjustment Methods 0.000 description 1
- 238000005192 partition Methods 0.000 description 1
- 230000002085 persistent effect Effects 0.000 description 1
- 238000009522 phase III clinical trial Methods 0.000 description 1
- 239000008055 phosphate buffer solution Substances 0.000 description 1
- 239000002953 phosphate buffered saline Substances 0.000 description 1
- 229920000647 polyepoxide Polymers 0.000 description 1
- 229920000642 polymer Polymers 0.000 description 1
- 229920000098 polyolefin Polymers 0.000 description 1
- 239000000256 polyoxyethylene sorbitan monolaurate Substances 0.000 description 1
- 235000010486 polyoxyethylene sorbitan monolaurate Nutrition 0.000 description 1
- 239000000244 polyoxyethylene sorbitan monooleate Substances 0.000 description 1
- 235000010482 polyoxyethylene sorbitan monooleate Nutrition 0.000 description 1
- 229940068977 polysorbate 20 Drugs 0.000 description 1
- 229920000053 polysorbate 80 Polymers 0.000 description 1
- 229940068968 polysorbate 80 Drugs 0.000 description 1
- 230000001737 promoting effect Effects 0.000 description 1
- 230000001681 protective effect Effects 0.000 description 1
- 230000002685 pulmonary effect Effects 0.000 description 1
- 230000000717 retained effect Effects 0.000 description 1
- 210000005245 right atrium Anatomy 0.000 description 1
- 210000005241 right ventricle Anatomy 0.000 description 1
- 230000005070 ripening Effects 0.000 description 1
- 230000000630 rising effect Effects 0.000 description 1
- 239000012266 salt solution Substances 0.000 description 1
- 229920006395 saturated elastomer Polymers 0.000 description 1
- 229910052708 sodium Inorganic materials 0.000 description 1
- 239000011734 sodium Substances 0.000 description 1
- URLJMZWTXZTZRR-UHFFFAOYSA-N sodium myristyl sulfate Chemical compound CCCCCCCCCCCCCCOS(O)(=O)=O URLJMZWTXZTZRR-UHFFFAOYSA-N 0.000 description 1
- 239000007787 solid Substances 0.000 description 1
- 238000012859 sterile filling Methods 0.000 description 1
- 239000008223 sterile water Substances 0.000 description 1
- 230000001954 sterilising effect Effects 0.000 description 1
- 238000004659 sterilization and disinfection Methods 0.000 description 1
- 239000000758 substrate Substances 0.000 description 1
- 238000011477 surgical intervention Methods 0.000 description 1
- 238000001356 surgical procedure Methods 0.000 description 1
- 230000008961 swelling Effects 0.000 description 1
- 208000011580 syndromic disease Diseases 0.000 description 1
- 230000007704 transition Effects 0.000 description 1
- 208000029257 vision disease Diseases 0.000 description 1
- 230000000007 visual effect Effects 0.000 description 1
- 230000004393 visual impairment Effects 0.000 description 1
- 239000008215 water for injection Substances 0.000 description 1
- 238000003466 welding Methods 0.000 description 1
Classifications
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B65—CONVEYING; PACKING; STORING; HANDLING THIN OR FILAMENTARY MATERIAL
- B65B—MACHINES, APPARATUS OR DEVICES FOR, OR METHODS OF, PACKAGING ARTICLES OR MATERIALS; UNPACKING
- B65B3/00—Packaging plastic material, semiliquids, liquids or mixed solids and liquids, in individual containers or receptacles, e.g. bags, sacks, boxes, cartons, cans, or jars
- B65B3/003—Filling medical containers such as ampoules, vials, syringes or the like
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/10—Dispersions; Emulsions
- A61K9/12—Aerosols; Foams
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B17/00—Surgical instruments, devices or methods
- A61B17/00008—Vein tendon strippers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B17/00—Surgical instruments, devices or methods
- A61B17/00491—Surgical glue applicators
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B17/00—Surgical instruments, devices or methods
- A61B17/12—Surgical instruments, devices or methods for ligaturing or otherwise compressing tubular parts of the body, e.g. blood vessels or umbilical cord
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B17/00—Surgical instruments, devices or methods
- A61B17/12—Surgical instruments, devices or methods for ligaturing or otherwise compressing tubular parts of the body, e.g. blood vessels or umbilical cord
- A61B17/12022—Occluding by internal devices, e.g. balloons or releasable wires
- A61B17/12099—Occluding by internal devices, e.g. balloons or releasable wires characterised by the location of the occluder
- A61B17/12109—Occluding by internal devices, e.g. balloons or releasable wires characterised by the location of the occluder in a blood vessel
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B17/00—Surgical instruments, devices or methods
- A61B17/12—Surgical instruments, devices or methods for ligaturing or otherwise compressing tubular parts of the body, e.g. blood vessels or umbilical cord
- A61B17/12022—Occluding by internal devices, e.g. balloons or releasable wires
- A61B17/12131—Occluding by internal devices, e.g. balloons or releasable wires characterised by the type of occluding device
- A61B17/12181—Occluding by internal devices, e.g. balloons or releasable wires characterised by the type of occluding device formed by fluidized, gelatinous or cellular remodelable materials, e.g. embolic liquids, foams or extracellular matrices
- A61B17/12186—Occluding by internal devices, e.g. balloons or releasable wires characterised by the type of occluding device formed by fluidized, gelatinous or cellular remodelable materials, e.g. embolic liquids, foams or extracellular matrices liquid materials adapted to be injected
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/075—Ethers or acetals
- A61K31/08—Ethers or acetals acyclic, e.g. paraformaldehyde
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/02—Inorganic compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
- A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/20—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing sulfur, e.g. dimethyl sulfoxide [DMSO], docusate, sodium lauryl sulfate or aminosulfonic acids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
- A61K47/32—Macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. carbomers, poly(meth)acrylates, or polyvinyl pyrrolidone
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/10—Dispersions; Emulsions
- A61K9/12—Aerosols; Foams
- A61K9/122—Foams; Dry foams
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/10—Dispersions; Emulsions
- A61K9/12—Aerosols; Foams
- A61K9/124—Aerosols; Foams characterised by the propellant
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M5/00—Devices for bringing media into the body in a subcutaneous, intra-vascular or intramuscular way; Accessories therefor, e.g. filling or cleaning devices, arm-rests
- A61M5/14—Infusion devices, e.g. infusing by gravity; Blood infusion; Accessories therefor
- A61M5/142—Pressure infusion, e.g. using pumps
- A61M5/145—Pressure infusion, e.g. using pumps using pressurised reservoirs, e.g. pressurised by means of pistons
- A61M5/155—Pressure infusion, e.g. using pumps using pressurised reservoirs, e.g. pressurised by means of pistons pressurised by gas introduced into the reservoir
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M5/00—Devices for bringing media into the body in a subcutaneous, intra-vascular or intramuscular way; Accessories therefor, e.g. filling or cleaning devices, arm-rests
- A61M5/178—Syringes
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P41/00—Drugs used in surgical methods, e.g. surgery adjuvants for preventing adhesion or for vitreum substitution
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/14—Vasoprotectives; Antihaemorrhoidals; Drugs for varicose therapy; Capillary stabilisers
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01F—MIXING, e.g. DISSOLVING, EMULSIFYING OR DISPERSING
- B01F23/00—Mixing according to the phases to be mixed, e.g. dispersing or emulsifying
- B01F23/20—Mixing gases with liquids
- B01F23/23—Mixing gases with liquids by introducing gases into liquid media, e.g. for producing aerated liquids
- B01F23/235—Mixing gases with liquids by introducing gases into liquid media, e.g. for producing aerated liquids for making foam
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01F—MIXING, e.g. DISSOLVING, EMULSIFYING OR DISPERSING
- B01F25/00—Flow mixers; Mixers for falling materials, e.g. solid particles
- B01F25/40—Static mixers
- B01F25/45—Mixers in which the materials to be mixed are pressed together through orifices or interstitial spaces, e.g. between beads
- B01F25/451—Mixers in which the materials to be mixed are pressed together through orifices or interstitial spaces, e.g. between beads characterised by means for moving the materials to be mixed or the mixture
- B01F25/4512—Mixers in which the materials to be mixed are pressed together through orifices or interstitial spaces, e.g. between beads characterised by means for moving the materials to be mixed or the mixture with reciprocating pistons
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01F—MIXING, e.g. DISSOLVING, EMULSIFYING OR DISPERSING
- B01F25/00—Flow mixers; Mixers for falling materials, e.g. solid particles
- B01F25/40—Static mixers
- B01F25/45—Mixers in which the materials to be mixed are pressed together through orifices or interstitial spaces, e.g. between beads
- B01F25/452—Mixers in which the materials to be mixed are pressed together through orifices or interstitial spaces, e.g. between beads characterised by elements provided with orifices or interstitial spaces
- B01F25/4523—Mixers in which the materials to be mixed are pressed together through orifices or interstitial spaces, e.g. between beads characterised by elements provided with orifices or interstitial spaces the components being pressed through sieves, screens or meshes which obstruct the whole diameter of the tube
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01F—MIXING, e.g. DISSOLVING, EMULSIFYING OR DISPERSING
- B01F33/00—Other mixers; Mixing plants; Combinations of mixers
- B01F33/50—Movable or transportable mixing devices or plants
- B01F33/501—Movable mixing devices, i.e. readily shifted or displaced from one place to another, e.g. portable during use
- B01F33/5011—Movable mixing devices, i.e. readily shifted or displaced from one place to another, e.g. portable during use portable during use, e.g. hand-held
- B01F33/50112—Movable mixing devices, i.e. readily shifted or displaced from one place to another, e.g. portable during use portable during use, e.g. hand-held of the syringe or cartridge type
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B65—CONVEYING; PACKING; STORING; HANDLING THIN OR FILAMENTARY MATERIAL
- B65B—MACHINES, APPARATUS OR DEVICES FOR, OR METHODS OF, PACKAGING ARTICLES OR MATERIALS; UNPACKING
- B65B31/00—Packaging articles or materials under special atmospheric or gaseous conditions; Adding propellants to aerosol containers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B17/00—Surgical instruments, devices or methods
- A61B17/12—Surgical instruments, devices or methods for ligaturing or otherwise compressing tubular parts of the body, e.g. blood vessels or umbilical cord
- A61B17/12022—Occluding by internal devices, e.g. balloons or releasable wires
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B17/00—Surgical instruments, devices or methods
- A61B17/00491—Surgical glue applicators
- A61B2017/00495—Surgical glue applicators for two-component glue
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/08—Solutions
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M16/00—Devices for influencing the respiratory system of patients by gas treatment, e.g. ventilators; Tracheal tubes
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M2202/00—Special media to be introduced, removed or treated
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M2210/00—Anatomical parts of the body
- A61M2210/08—Limbs
- A61M2210/086—Legs
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M2210/00—Anatomical parts of the body
- A61M2210/12—Blood circulatory system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M5/00—Devices for bringing media into the body in a subcutaneous, intra-vascular or intramuscular way; Accessories therefor, e.g. filling or cleaning devices, arm-rests
- A61M5/178—Syringes
- A61M5/19—Syringes having more than one chamber, e.g. including a manifold coupling two parallelly aligned syringes through separate channels to a common discharge assembly
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- Engineering & Computer Science (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Surgery (AREA)
- Epidemiology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Dispersion Chemistry (AREA)
- Heart & Thoracic Surgery (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Biomedical Technology (AREA)
- Medical Informatics (AREA)
- Molecular Biology (AREA)
- Vascular Medicine (AREA)
- General Chemical & Material Sciences (AREA)
- Reproductive Health (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Inorganic Chemistry (AREA)
- Organic Chemistry (AREA)
- Mechanical Engineering (AREA)
- Dermatology (AREA)
- Anesthesiology (AREA)
- Hematology (AREA)
- Rheumatology (AREA)
- Cardiology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
- Infusion, Injection, And Reservoir Apparatuses (AREA)
- Polyurethanes Or Polyureas (AREA)
- Manufacture Of Porous Articles, And Recovery And Treatment Of Waste Products (AREA)
- Emulsifying, Dispersing, Foam-Producing Or Wetting Agents (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Emergency Medicine (AREA)
Applications Claiming Priority (5)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GB0326768A GB0326768D0 (en) | 2003-11-17 | 2003-11-17 | Generation of therapeutic microfoam |
| US54286704P | 2004-02-10 | 2004-02-10 | |
| US54286604P | 2004-02-10 | 2004-02-10 | |
| GB0422307A GB0422307D0 (en) | 2004-10-07 | 2004-10-07 | Generation and delivery of therapeutic microfoam |
| PCT/GB2004/004848 WO2005048977A2 (en) | 2003-11-17 | 2004-11-17 | Therapeutic foam comprising a sclerosing solution |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| EA200600985A1 EA200600985A1 (ru) | 2006-10-27 |
| EA009362B1 true EA009362B1 (ru) | 2007-12-28 |
Family
ID=43013737
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| EA200600985A EA009362B1 (ru) | 2003-11-17 | 2004-11-17 | Терапевтическая пена |
Country Status (27)
| Country | Link |
|---|---|
| US (8) | US7763269B2 (enExample) |
| EP (4) | EP1791519B1 (enExample) |
| JP (4) | JP2007511591A (enExample) |
| KR (4) | KR20060127001A (enExample) |
| CN (1) | CN1960705B (enExample) |
| AT (1) | ATE453379T2 (enExample) |
| AU (4) | AU2004290959A1 (enExample) |
| BR (1) | BRPI0416611B8 (enExample) |
| CA (4) | CA2546227A1 (enExample) |
| CY (2) | CY1110513T1 (enExample) |
| CZ (1) | CZ2006315A3 (enExample) |
| DE (2) | DE602004024925D1 (enExample) |
| DK (2) | DK1701701T3 (enExample) |
| EA (1) | EA009362B1 (enExample) |
| EC (1) | ECSP066574A (enExample) |
| ES (2) | ES2330341T5 (enExample) |
| IL (1) | IL175672A (enExample) |
| IN (1) | IN2014DN07569A (enExample) |
| MA (1) | MA31041B1 (enExample) |
| MX (1) | MXPA06005526A (enExample) |
| NO (1) | NO20062866L (enExample) |
| NZ (1) | NZ547265A (enExample) |
| OA (1) | OA13287A (enExample) |
| PL (3) | PL223344B1 (enExample) |
| PT (2) | PT1701701E (enExample) |
| SI (3) | SI1701701T1 (enExample) |
| WO (4) | WO2005048984A1 (enExample) |
Cited By (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| RU2693344C1 (ru) * | 2018-07-05 | 2019-07-02 | Федеральное Государственное Бюджетное Образовательное Учреждение Высшего Образования "Московский государственный медико-стоматологический университет имени А.И. Евдокимова" Министерства здравоохранения Российской Федерации (ФГБОУ ВО МГМСУ имени А.И. Евдокимова Минздрава России) | Способ склеротерапии микропенной артерио-венозных мальформаций челюстно-лицевой области пациента под ультразвуковым контролем |
| RU2780546C1 (ru) * | 2021-10-22 | 2022-09-27 | Федеральное государственное бюджетное учреждение Национальный медицинский исследовательский центр "Центральный научно-исследовательский институт стоматологии и челюстно-лицевой хирургии" Министерства здравоохранения Российской Федерации | Способ деструкции венозных и лимфовенозных мальформаций путем прошивания, склерозирования и компрессии |
Families Citing this family (101)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB9912356D0 (en) * | 1999-05-26 | 1999-07-28 | Btg Int Ltd | Generation of microfoam |
| GB0028692D0 (en) | 2000-11-24 | 2001-01-10 | Btg Int Ltd | Generation of therapeutic microform |
| US8512680B2 (en) * | 2001-08-08 | 2013-08-20 | Btg International Ltd. | Injectables in foam, new pharmaceutical applications |
| WO2005048984A1 (en) * | 2003-11-17 | 2005-06-02 | Btg International Limited | Methods of preparing a foam comprising a sclerosing agent |
| US8048439B2 (en) * | 2003-11-17 | 2011-11-01 | Btg International Ltd. | Therapeutic foam |
| ITMI20041056A1 (it) * | 2004-05-26 | 2004-08-26 | Garrido Antonio Luis Cabrera | Uso in campo medico diagnostico e flebo logico di una kiscela di gas sterili e fisiologicamente accettabili |
| EP1901712B1 (en) * | 2005-05-13 | 2012-06-20 | BTG International Limited | Therapeutic sclerosing foam made preferably from xenon |
| GB0509824D0 (en) * | 2005-05-13 | 2005-06-22 | Btg Int Ltd | Therapeutic foam |
| GB0509819D0 (en) * | 2005-05-13 | 2005-06-22 | Btg Int Ltd | Therapeutic foam |
| GB0509845D0 (en) | 2005-05-13 | 2005-06-22 | Btg Int Ltd | Preparation of therapeutic foam |
| WO2007045897A1 (en) | 2005-10-21 | 2007-04-26 | Btg International Limited | Aerosol valve |
| US20080243068A1 (en) * | 2005-12-29 | 2008-10-02 | Kamal Ramzipoor | Methods and apparatus for treatment of venous insufficiency |
| AU2013213741B2 (en) * | 2006-01-17 | 2016-01-28 | Baxter Healthcare Sa | Device, system and method for mixing |
| US20090038701A1 (en) | 2006-01-17 | 2009-02-12 | Baxter International Inc. | Device, system and method for mixing |
| CN101370433B (zh) * | 2006-01-17 | 2012-08-08 | 巴克斯特国际公司 | 用于混合的装置、系统和方法 |
| US9486594B2 (en) | 2006-11-27 | 2016-11-08 | Frank Levy | Portable medical gas delivery system |
| US8876749B2 (en) | 2006-11-27 | 2014-11-04 | Frank Levy | Apparatus and process for producing CO2 enriched medical foam |
| US9662435B2 (en) | 2006-01-31 | 2017-05-30 | Frank Levy | System and method for the effective, reliable and foolproof delivery of controlled amounts of a medical fluid |
| US20100101579A1 (en) * | 2006-11-27 | 2010-04-29 | Frank Levy | Portable Medical Gas Delivery System |
| EP2010249A2 (en) | 2006-04-04 | 2009-01-07 | Vnus Medical Technologies, Inc. | Method and apparatus for generating vascular treatment foam |
| EP2015702A2 (en) * | 2006-05-11 | 2009-01-21 | Dentsply International Inc. | Aerosol delivery system for dispensing dental compositions |
| ES2289947B1 (es) * | 2006-07-25 | 2009-02-16 | Universidade De Santiago De Compostela | Microespuma esclerosante con co2, dispositivo de preparacion y sus aplicaciones. |
| US10350399B2 (en) | 2006-11-27 | 2019-07-16 | Frank Levy | Apparatus and method for producing an enriched medical suspension of carbon dioxide |
| US12377251B2 (en) | 2006-11-27 | 2025-08-05 | Frank Levy | Apparatus and method for producing an enriched medical suspension of carbon dioxide |
| US10322271B2 (en) | 2006-11-27 | 2019-06-18 | Frank Levy | Delivery system and method for the effective and reliable delivery of controlled amounts of a medical fluid |
| US10155093B2 (en) | 2006-11-27 | 2018-12-18 | Frank Levy | Apparatus and method for producing CO2 enriched medical foam |
| US9427522B2 (en) | 2006-11-27 | 2016-08-30 | Frank Levy | Delivery system for the effective and reliable delivery of controlled amounts of a medical fluid |
| US20190070397A1 (en) * | 2006-11-27 | 2019-03-07 | Frank Levy | Apparatus and method for producing co2 enriched medical foam |
| US10149935B2 (en) | 2006-11-27 | 2018-12-11 | Frank Levy | Delivery system and method for the effective and reliable delivery of controlled amounts of a medical fluid |
| US11185671B2 (en) | 2006-11-27 | 2021-11-30 | Frank Levy | Apparatus and process for producing CO2 enriched medical foam |
| US11833320B2 (en) | 2006-11-27 | 2023-12-05 | Frank Levy | Apparatus and process for producing CO2 enriched medical foam |
| US11712510B2 (en) | 2006-11-27 | 2023-08-01 | Frank Levy | Delivery system and method for the effective, reliable and foolproof delivery of controlled amounts of a medical fluid |
| US20080140002A1 (en) * | 2006-12-06 | 2008-06-12 | Kamal Ramzipoor | System for delivery of biologically active substances with actuating three dimensional surface |
| DE112007003084T5 (de) | 2006-12-21 | 2009-10-29 | Btg International Ltd. | Vorrichtung und Verfahren zur Herstellung von therapeutischem Schaum |
| CA2673166C (en) * | 2007-01-25 | 2015-09-22 | Hyperbranch Medical Technology, Inc. | Applicators for multiple component formulations and the like, and methods of use thereof |
| KR101562199B1 (ko) * | 2007-11-08 | 2015-10-21 | 넥스메드 홀딩스 인코포레이티드 | 서로 개별적으로 저장된 성분을 혼합하고 분배하기 위한 디바이스 및 시스템 |
| US8512740B2 (en) | 2008-03-26 | 2013-08-20 | Baxter International Inc. | Fibrin foam and process for making |
| US8753670B2 (en) | 2008-03-26 | 2014-06-17 | Baxter International Inc. | Fibrin foam and process |
| US20110139821A1 (en) * | 2008-09-22 | 2011-06-16 | Medmix Systems Ag | Connector having mixing element for discharge arrangement |
| US8560968B1 (en) * | 2009-03-26 | 2013-10-15 | Vinod Nair | Method and apparatus for evaluating a heart patient |
| US8376989B2 (en) * | 2009-03-30 | 2013-02-19 | Covidien Lp | Compartmented syringe |
| EP2475308A1 (en) | 2009-09-08 | 2012-07-18 | Baxter International Inc | Reconstitution and applicator system for wound sealant product |
| US20110082340A1 (en) * | 2009-10-07 | 2011-04-07 | Tyco Healthercare Group LP | Foam collar for surgical access devices |
| US8641661B2 (en) | 2010-01-05 | 2014-02-04 | Baxter International Inc. | Mixing system, kit and mixer adapter |
| EP2384703A1 (en) * | 2010-05-05 | 2011-11-09 | Bioadhesives Meditech Solutions, S.L. | Device for dispensing a two-component tissue adhesive or sealant |
| NZ606713A (en) * | 2010-08-06 | 2015-04-24 | Hospira Australia Pty Ltd | Vial preparation method and system |
| WO2013070692A1 (en) | 2011-11-07 | 2013-05-16 | Battelle Memorial Institute | Processes for delivery of viscous drug therapies |
| US9937317B2 (en) * | 2012-01-30 | 2018-04-10 | Ipsumpro, S.L. | Modified medical syringe with a flow regulator for the administration of local anaesthetic |
| WO2013155009A1 (en) | 2012-04-09 | 2013-10-17 | Becton, Dickinson And Company | Injection mechanism utilizing a vial |
| ES2843482T3 (es) * | 2012-04-24 | 2021-07-19 | Angioclinic Ag | Composición para tratar la insuficiencia venosa y las venas varicosas |
| US10052107B2 (en) * | 2012-06-25 | 2018-08-21 | Arsenal Medical, Inc. | Systems and methods for the treatment of aneurysms |
| US8968449B2 (en) * | 2012-07-04 | 2015-03-03 | Vki Technologies Inc. | Spout, system, and method for producing a foam |
| WO2014031150A1 (en) * | 2012-08-24 | 2014-02-27 | St. Jude Medical Puerto Rico Llc | Sealant storage, preparation, and delivery systems and related methods |
| PL2722008T3 (pl) * | 2012-10-16 | 2018-07-31 | Erbe Elektromedizin Gmbh | Dysza do doprowadzania materiału biologicznego, zwłaszcza komórek, urządzenie medyczne z taką dyszą, zastosowanie dyszy, sposób mieszania płynów i urządzenie |
| EP2925391B1 (en) * | 2012-11-30 | 2017-05-03 | Unitract Syringe Pty Ltd | Combination plunger device for a dual chamber mixing syringe |
| EP3020343B1 (en) * | 2013-07-08 | 2019-06-19 | Terumo Kabushiki Kaisha | Application tool |
| US10111980B2 (en) | 2013-12-11 | 2018-10-30 | Ferrosan Medical Devices A/S | Dry composition comprising an extrusion enhancer |
| US10000009B2 (en) * | 2014-02-05 | 2018-06-19 | Nathan Christopher Maier | Sterile environment for additive manufacturing |
| WO2015125736A1 (ja) * | 2014-02-19 | 2015-08-27 | 株式会社モリタ製作所 | 医療用機器要素、医療用機器、医療用機器構成部品、医療用ハンドピース、医療用機器要素の製造方法、及び医療用切削装置 |
| WO2015153828A1 (en) | 2014-04-04 | 2015-10-08 | Hyperbranch Medical Technology, Inc. | Extended tip spray applicator for two-component surgical selant, and methods of use thereof |
| EP3131473B1 (en) | 2014-04-18 | 2019-07-31 | Covidien LP | Mixing nozzle |
| WO2015160871A1 (en) * | 2014-04-18 | 2015-10-22 | Covidien Lp | Mixing syringe |
| CA2950483C (en) | 2014-06-03 | 2022-06-28 | Antoni PUIG DOMENECH | Methods, devices, systems and kits for preparing compositions for care and repair of varicose veins |
| EP2962681A1 (en) * | 2014-07-03 | 2016-01-06 | Swiss VX Venentherapie und Forschung GmbH | Devices and methods for injectable vascular sclerofoams using a carrier made of human blood and uses thereof |
| PL2982444T3 (pl) * | 2014-08-05 | 2020-05-18 | Goizper, S. Coop. | Ciśnieniowe urządzenie natryskowe |
| US9687455B2 (en) | 2014-08-14 | 2017-06-27 | John Daniel Dobak | Sodium tetradecyl sulfate formulations for treatment of adipose tissue |
| US9351945B1 (en) * | 2015-02-27 | 2016-05-31 | John Daniel Dobak, III | Reduction of adipose tissue |
| WO2017011668A1 (en) * | 2015-07-14 | 2017-01-19 | Boston Scientific Scimed, Inc. | Gel delivery catheters, systems, and methods |
| US11415019B2 (en) | 2015-12-11 | 2022-08-16 | General Electric Company | Meta-stable detergent based foam cleaning system and method for gas turbine engines |
| EP3251654A1 (de) * | 2016-05-30 | 2017-12-06 | Chemische Fabrik Kreussler & Co. Gmbh | Nichtionische tenside zur reduktion von fettgewebe |
| GB201612925D0 (en) * | 2016-07-26 | 2016-09-07 | Provensis Ltd | Method and device for generating injectable foam |
| GB201612948D0 (en) * | 2016-07-26 | 2016-09-07 | Provensis Ltd | syringe for administering foam |
| IL248775A0 (en) * | 2016-11-06 | 2017-02-28 | Technion Res & Dev Foundation | Administering drugs to the lung using foam |
| GB201703299D0 (en) * | 2017-03-01 | 2017-04-12 | Triple Line Tech Ltd | Apparatus and method for generating a microfoam |
| JP2020515592A (ja) * | 2017-03-27 | 2020-05-28 | ドン,ヨンファ | 連鎖薬物構造およびその製造装置と保存装置 |
| RU2659632C1 (ru) * | 2017-04-04 | 2018-07-03 | Федеральное государственное бюджетное образовательное учреждение высшего образования "Рязанский государственный медицинский университет имени академика И.П. Павлова" Министерства здравоохранения Российской Федерации | Устройство для вспенивания и введения лекарственного препарата |
| AU2018313859B2 (en) * | 2017-08-08 | 2024-08-01 | Tetrous, Inc. | Therapeutic gas infused cosmetic and methods of infusion |
| US10786433B2 (en) * | 2017-09-13 | 2020-09-29 | William J Moore | Buffering agent cartridge |
| JP2019074486A (ja) * | 2017-10-19 | 2019-05-16 | 大陽日酸株式会社 | 二酸化炭素ガス中の窒素ガス分析方法及び装置 |
| US11185643B2 (en) | 2018-04-06 | 2021-11-30 | Frank Levy | Apparatus and method for producing an enriched medical suspension |
| WO2019195723A1 (en) | 2018-04-06 | 2019-10-10 | Frank Levy | Apparatus and method for producing an enriched medical contrast suspension |
| JP7530647B2 (ja) * | 2018-08-21 | 2024-08-08 | バスキュラー バルセロナ デバイシズ,エス.エル. | 静脈瘤のケアおよび修復用の組成物を調製するための方法、装置、システムおよびキット |
| US11517527B2 (en) * | 2018-11-05 | 2022-12-06 | Ethicon, Inc. | Systems, devices and methods for making and expressing foam used in medical procedures |
| WO2020231429A1 (en) * | 2019-05-10 | 2020-11-19 | Coll Mazzei Jose Vicente | New use of a milk frother apparatus and a method for the preparation of a therapeutic foam for the treatment of varicose veins and other medical conditions. |
| CN110123757B (zh) * | 2019-05-28 | 2020-09-01 | 山东大学齐鲁医院 | 一种应用于治疗脉管异常的乙醇泡沫硬化剂及制备方法 |
| EP3756705A1 (de) * | 2019-06-27 | 2020-12-30 | Adhesys Medical GmbH | Applikator für einen zwei-komponenten gewebekleber |
| US11912975B2 (en) | 2019-09-02 | 2024-02-27 | Mirai Medical Limited | Electroporation apparatus and method |
| EP3798138A1 (en) * | 2019-09-30 | 2021-03-31 | SCHOTT Schweiz AG | Device and process for stoppering from below |
| CA3163519A1 (en) | 2019-12-03 | 2021-06-10 | Boston Scientific Scimed, Inc. | Agent delivery devices |
| EP4106773A1 (en) * | 2020-02-18 | 2022-12-28 | Aviation Works Limited | Oxygen/carbon dioxide compositions for medical uses |
| CN111437504B (zh) * | 2020-04-28 | 2022-02-18 | 山东大学齐鲁医院 | 一种用于产生稳定泡沫的三通阀 |
| WO2022152930A1 (en) * | 2021-01-18 | 2022-07-21 | Bonsens Ab | A swirl nozzle and methods of fabricating the same |
| EP4387761A1 (en) * | 2021-08-19 | 2024-06-26 | Nanortopedi Teknoloji Sanayi Ve Ticaret A.S. | Microfluidic injection device and method for use in cartilage repair |
| US12409271B2 (en) | 2022-04-25 | 2025-09-09 | Frank Levy | Apparatus and method for producing an enriched medical suspension |
| CN115708693B (zh) * | 2022-10-24 | 2024-02-27 | 无忧跳动医疗科技(深圳)有限公司 | 一种全自动发泡装置及方法 |
| US20240149020A1 (en) | 2022-11-04 | 2024-05-09 | Controlled Delivery Systems, Inc. | Catheters for the aspiration controlled delivery of closure agents |
| AU2023371657A1 (en) | 2022-11-04 | 2025-05-15 | Solvein Inc. | Catheters and related methods for aspiration and controlled delivery of closure agents |
| KR102744414B1 (ko) * | 2022-11-15 | 2024-12-19 | 원광대학교산학협력단 | 반응 약물이 충전된 시린지 |
| US20240165294A1 (en) * | 2022-11-23 | 2024-05-23 | Case Western Reserve University | Tunable, stable sclerosing foam for vascular interventions |
| DE102023112792A1 (de) * | 2023-05-15 | 2024-11-21 | Santa Isabel International Foundation | Mikroschaum-Generierungssystem mit Reaktionsbehälter, Kartusche und automatisierten System, Verfahren und Computerprogramm zum Erzeugen eines Mikroschaums |
| PL445663A1 (pl) * | 2023-07-24 | 2025-01-27 | Biotreat Vascular Spółka Z Ograniczoną Odpowiedzialnością | Urządzenie do podawania kleju i zastosowanie tego urządzenia w chirurgii naczyniowej, w szczególności do endowaskularnego podawania kleju |
Citations (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2000072821A1 (en) * | 1999-05-26 | 2000-12-07 | Btg International Limited | Generation of therapeutic microfoam |
| WO2002041872A1 (en) * | 2000-11-24 | 2002-05-30 | Btg International Limited | Generation of therapeutic microfoam |
| WO2004062461A2 (en) * | 2003-01-10 | 2004-07-29 | Btg International Limited | Therapeutic microfoam |
Family Cites Families (82)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US2630183A (en) * | 1950-01-26 | 1953-03-03 | Foutz Clinton Root | Apparatus for forming and projecting a foam mixture |
| US2724383A (en) * | 1951-06-28 | 1955-11-22 | Compule Corp | Combined mixing container structure and hypodermic syringe for segregated ingredients of hypodermically injectable preparations |
| FR1547768A (fr) | 1967-10-09 | 1968-11-29 | Récipient remplissable à dispositif décompresseur | |
| US3670786A (en) * | 1970-06-02 | 1972-06-20 | American Home Prod | Container filling apparatus |
| FR2105332A5 (enExample) * | 1970-09-01 | 1972-04-28 | Oreal | |
| US3767085A (en) * | 1971-08-02 | 1973-10-23 | J Cannon | Mixing syringe |
| US3763900A (en) * | 1971-09-10 | 1973-10-09 | Milchwirlschaftliche Forschung | Process for sterilizing and filling aerosol containers |
| US3955720A (en) * | 1972-11-15 | 1976-05-11 | Malone David C | Low pressure dispensing apparatus with air pump |
| US3970219A (en) * | 1975-03-03 | 1976-07-20 | Spitzer Joseph G | Aerosol containers for foaming and delivering aerosols and process |
| US4019657A (en) * | 1975-03-03 | 1977-04-26 | Spitzer Joseph G | Aerosol containers for foaming and delivering aerosols |
| US4019357A (en) * | 1975-11-10 | 1977-04-26 | Nippon Concrete Industries Co. Ltd. | Method of making reinforcements for concrete |
| US4040420A (en) * | 1976-04-22 | 1977-08-09 | General Dynamics | Packaging and dispensing kit |
| US4127131A (en) * | 1977-06-20 | 1978-11-28 | Johnson & Johnson | Hub assembly for use in the filtration of fluids and method of making the same |
| FR2445018A1 (fr) | 1978-12-22 | 1980-07-18 | Anvar | Tube multiplicateur d'electrons a champ magnetique axial |
| US4276885A (en) * | 1979-05-04 | 1981-07-07 | Rasor Associates, Inc | Ultrasonic image enhancement |
| US4292975A (en) * | 1979-08-20 | 1981-10-06 | Carolyn Champion | Brassiere |
| US4358107A (en) * | 1980-02-19 | 1982-11-09 | Nissen George P | Weight lifting machine |
| US4292972A (en) * | 1980-07-09 | 1981-10-06 | E. R. Squibb & Sons, Inc. | Lyophilized hydrocolloio foam |
| DE3050812C2 (de) | 1980-12-23 | 1985-03-21 | B. Braun Melsungen Ag, 3508 Melsungen | Katheterisierungsvorrichtung |
| DE3048744A1 (de) | 1980-12-23 | 1982-07-22 | Metzeler Kautschuk GmbH, 8000 München | Anordnung zum abdichten einer mehrscheibenverglasung |
| DE3048774C2 (de) | 1980-12-23 | 1984-03-08 | B. Braun Melsungen Ag, 3508 Melsungen | Katheterisierungsvorrichtung |
| DE3141641A1 (de) * | 1981-10-16 | 1983-04-28 | Schering Ag, 1000 Berlin Und 4619 Bergkamen | Ultraschall-kontrastmittel und dessen herstellung |
| US4718433A (en) | 1983-01-27 | 1988-01-12 | Feinstein Steven B | Contrast agents for ultrasonic imaging |
| US4538920A (en) * | 1983-03-03 | 1985-09-03 | Minnesota Mining And Manufacturing Company | Static mixing device |
| US5141738A (en) * | 1983-04-15 | 1992-08-25 | Schering Aktiengesellschaft | Ultrasonic contrast medium comprising gas bubbles and solid lipophilic surfactant-containing microparticles and use thereof |
| DE3313947A1 (de) | 1983-04-15 | 1984-10-18 | Schering AG, 1000 Berlin und 4709 Bergkamen | Mikropartikel und gasblaeschen enthaltende ultraschall-kontrastmittel |
| DE3324754A1 (de) | 1983-07-06 | 1985-01-17 | Schering AG, 1000 Berlin und 4709 Bergkamen | Ultraschallkontrastmittel sowie dessen herstellung |
| DE3417182A1 (de) | 1984-05-09 | 1985-11-14 | Gerald Dr. 8000 München Hauer | Spritzen-set |
| US4719433A (en) * | 1984-09-14 | 1988-01-12 | Siemens Aktiengesellschaft | Attenuation bead for the suppression of interference radiation |
| GB8522813D0 (en) | 1985-09-16 | 1985-10-23 | Unilever Plc | Package |
| DE8704600U1 (de) | 1987-03-27 | 1987-10-15 | Cocon Kunststoffen B.V., Arkel | Vorrichtung zur gebrauchsfertigen Zubereitung der beiden Komponenten eines zweikomponentigen Montageschaums, insbesondere Polyurethanschaums |
| IE61591B1 (en) | 1987-12-29 | 1994-11-16 | Molecular Biosystems Inc | Concentrated stabilized microbubble-type ultrasonic imaging agent and method of production |
| US5425366A (en) * | 1988-02-05 | 1995-06-20 | Schering Aktiengesellschaft | Ultrasonic contrast agents for color Doppler imaging |
| AU635200B2 (en) | 1988-02-05 | 1993-03-18 | Schering Aktiengesellschaft Berlin Und Bergkamen | Ultrasonic contrast agents, process for producing them and their use as diagnostic and therapeutic agents |
| CH676456A5 (enExample) * | 1988-04-05 | 1991-01-31 | Supermatic Kunststoff Ag | |
| US4957656A (en) | 1988-09-14 | 1990-09-18 | Molecular Biosystems, Inc. | Continuous sonication method for preparing protein encapsulated microbubbles |
| FR2641202B1 (fr) * | 1989-01-03 | 1991-03-15 | Poizot Francis | Dispositif de production de mousse |
| US5542935A (en) * | 1989-12-22 | 1996-08-06 | Imarx Pharmaceutical Corp. | Therapeutic delivery systems related applications |
| US5733572A (en) * | 1989-12-22 | 1998-03-31 | Imarx Pharmaceutical Corp. | Gas and gaseous precursor filled microspheres as topical and subcutaneous delivery vehicles |
| US5084011A (en) * | 1990-01-25 | 1992-01-28 | Grady Daniel J | Method for oxygen therapy using hyperbarically oxygenated liquid |
| US5556610A (en) * | 1992-01-24 | 1996-09-17 | Bracco Research S.A. | Gas mixtures useful as ultrasound contrast media, contrast agents containing the media and method |
| US5064103A (en) * | 1990-05-23 | 1991-11-12 | Rjs Industries, Inc. | Foam dispenser having a plurality of sieves |
| JP2910784B2 (ja) * | 1990-09-14 | 1999-06-23 | 大和製罐株式会社 | エアゾール缶詰の製造方法 |
| ES2074725T3 (es) | 1990-10-05 | 1995-09-16 | Bracco Int Bv | Metodo para la preparacion de suspensiones estables de microesferas huecas llenas de gas adecuadas para ecografia ultrasonica. |
| ATE123930T1 (de) | 1990-12-28 | 1995-07-15 | Byk Gulden Lomberg Chem Fab | Darreichungsform für mikrobläschen- echokontrastmittel. |
| US5425580A (en) * | 1990-12-28 | 1995-06-20 | Byk Gulden Lomberg Chemische Fabrik Gmbh | Dosage form for micro-bubble echo contrast agents |
| DE4100470A1 (de) | 1991-01-09 | 1992-07-16 | Byk Gulden Lomberg Chem Fab | Echokontrastmittel |
| FR2672038B1 (fr) | 1991-01-25 | 1993-05-14 | Oreal | Dispositif distributeur de mousse a partir d'un recipient pressurise. |
| JP3231768B2 (ja) | 1991-09-17 | 2001-11-26 | ソーナス ファーマシューティカルス,インコーポレイテッド | 気体状超音波造影剤及び超音波造影剤として使用する気体の選定方法 |
| DE4301820C2 (de) * | 1993-01-23 | 1996-04-25 | Henkel Kgaa | Schäumende Emulsionen, Verfahren zu ihrer Herstellung und ihre Verwendung |
| FR2702196B1 (fr) * | 1993-03-05 | 1995-05-12 | Oreal | Distributeur de mousse sous pression. |
| NL9300517A (nl) | 1993-03-23 | 1994-10-17 | Airspray Int Bv | Schuimvormingssamenstel, een daarvoor geschikte spuitkop en een spuitbus die een dergelijk samenstel omvat. |
| US5695740A (en) | 1993-05-12 | 1997-12-09 | The Board Of Regents Of The University Of Nebraska | Perfluorocarbon ultrasound contrast agent comprising microbubbles containing a filmogenic protein and a saccharide |
| ES2068151B1 (es) * | 1993-06-23 | 1995-11-16 | Cabrera Garrido Juan | Microespuma inyectable para esclerosis. |
| DE69434119T3 (de) | 1993-07-30 | 2011-05-05 | Imcor Pharmaceutical Co., San Diego | Stabilisierte mikrogasbläschen-zusammensetzungen für echographie |
| US5798091A (en) * | 1993-07-30 | 1998-08-25 | Alliance Pharmaceutical Corp. | Stabilized gas emulsion containing phospholipid for ultrasound contrast enhancement |
| US5454805A (en) * | 1994-03-14 | 1995-10-03 | Brony; Seth K. | Medicine vial link for needleless syringes |
| DE4432993C1 (de) | 1994-09-16 | 1996-06-20 | Byk Gulden Lomberg Chem Fab | Mischeinrichtung für mittels einer Spritze zu verabreichende Mittel |
| US5623085A (en) * | 1994-09-23 | 1997-04-22 | Rohm And Haas Company | Method for reducing microfoam in a spray-applied waterborne composition |
| WO1996011162A1 (en) * | 1994-10-11 | 1996-04-18 | Monson James A | Dispensing apparatus for foaming compositions and method |
| TW319763B (enExample) | 1995-02-01 | 1997-11-11 | Epix Medical Inc | |
| GB9503119D0 (en) | 1995-02-17 | 1995-04-05 | Durand Ltd | Medication and apparatus and method of applying medication |
| NL1001366C2 (nl) | 1995-10-06 | 1997-04-08 | Airspray Int Bv | Inrichting voor het afgeven van een luchtvloeistofmengsel, in het bijzonder schuim en daarvoor bestemde bedieningseenheid. |
| JP2751899B2 (ja) | 1995-12-15 | 1998-05-18 | ソニー株式会社 | 光学ピックアップ装置 |
| JPH1081895A (ja) | 1996-09-05 | 1998-03-31 | Lion Corp | 漂白洗剤製品 |
| GB9823029D0 (en) | 1998-10-22 | 1998-12-16 | Giltech Ltd | Packaging system |
| FR2775433A1 (fr) | 1998-02-27 | 1999-09-03 | Alain Monfreux | Dispositif pour la production de mousse dans un corps de seringue |
| FR2775436A1 (fr) | 1998-02-27 | 1999-09-03 | Alain Monfreux | Dispositif pour l'administration parenterale d'une composition sous forme d'une mousse |
| FR2784296B1 (fr) * | 1998-09-18 | 2001-01-05 | Imedex Biomateriaux | Dispositif pour la formulation et la delivrance d'un melange, notamment pour l'application chirurgicale de ce melange |
| DE29819174U1 (de) | 1998-10-28 | 1999-01-28 | Kurt Vogelsang GmbH, 74855 Haßmersheim | Schutzkappe für eine Zweikomponenten-Lack-Sprühdose |
| ES1043183Y (es) | 1999-05-03 | 2000-04-01 | Mingo Fco Javier Garcia | Dispositivo para producir esclerosante espumado. |
| NL1012419C2 (nl) * | 1999-06-23 | 2000-12-28 | Airspray Nv | Spuitbus voor het afgeven van een vloeistof. |
| US6561237B1 (en) * | 2000-11-28 | 2003-05-13 | Brasscorp Ltd. | Apparatus and method for urging fluid into a pressurized system |
| GB2369996B (en) | 2000-12-18 | 2004-06-23 | S T D Pharmaceutical Products | Method and apparatus for producing an injectable foam |
| US6592251B2 (en) | 2001-01-26 | 2003-07-15 | Howmedica Osteonics Corp. | Cement mixing and dispensing device |
| DE60142311D1 (de) | 2001-08-08 | 2010-07-15 | Dominguez Maria Antonia Garcia-Olmedo | Injizierbarer schaum und neue pharmazeutische anwendungen dafür |
| GB0212047D0 (en) * | 2002-05-24 | 2002-07-03 | Btg Int Ltd | Generation of therapeutic microfoam |
| DE20218493U1 (de) | 2002-11-28 | 2004-04-08 | Chemische Fabrik Kreussler & Co. Gmbh | Vorrichtung zur Erzeugung von medizinischem Schaum |
| JP4333186B2 (ja) * | 2003-04-07 | 2009-09-16 | ソニー株式会社 | 通信システム及び通信照明装置 |
| US8048439B2 (en) * | 2003-11-17 | 2011-11-01 | Btg International Ltd. | Therapeutic foam |
| WO2005048984A1 (en) * | 2003-11-17 | 2005-06-02 | Btg International Limited | Methods of preparing a foam comprising a sclerosing agent |
| GB0509819D0 (en) * | 2005-05-13 | 2005-06-22 | Btg Int Ltd | Therapeutic foam |
-
2004
- 2004-11-17 WO PCT/GB2004/004846 patent/WO2005048984A1/en not_active Ceased
- 2004-11-17 PL PL380484A patent/PL223344B1/pl unknown
- 2004-11-17 DK DK04798564.3T patent/DK1701701T3/da active
- 2004-11-17 US US10/522,528 patent/US7763269B2/en active Active
- 2004-11-17 CZ CZ20060315A patent/CZ2006315A3/cs unknown
- 2004-11-17 AU AU2004290959A patent/AU2004290959A1/en not_active Abandoned
- 2004-11-17 JP JP2006540585A patent/JP2007511591A/ja active Pending
- 2004-11-17 BR BRPI0416611A patent/BRPI0416611B8/pt not_active IP Right Cessation
- 2004-11-17 EP EP04798550.2A patent/EP1791519B1/en not_active Expired - Lifetime
- 2004-11-17 EP EP04798564.3A patent/EP1701701B2/en not_active Expired - Lifetime
- 2004-11-17 IN IN7569DEN2014 patent/IN2014DN07569A/en unknown
- 2004-11-17 AU AU2004290963A patent/AU2004290963A1/en not_active Abandoned
- 2004-11-17 SI SI200431374T patent/SI1701701T1/sl unknown
- 2004-11-17 CN CN2004800339138A patent/CN1960705B/zh not_active Expired - Lifetime
- 2004-11-17 KR KR1020067012049A patent/KR20060127001A/ko not_active Withdrawn
- 2004-11-17 JP JP2006540581A patent/JP2007511590A/ja active Pending
- 2004-11-17 WO PCT/GB2004/004824 patent/WO2005048983A1/en not_active Ceased
- 2004-11-17 EP EP04798543A patent/EP1684718A1/en not_active Withdrawn
- 2004-11-17 ES ES04798566.8T patent/ES2330341T5/es not_active Expired - Lifetime
- 2004-11-17 DE DE602004024925T patent/DE602004024925D1/de not_active Expired - Lifetime
- 2004-11-17 PL PL04798564T patent/PL1701701T5/pl unknown
- 2004-11-17 AU AU2004290965A patent/AU2004290965B2/en not_active Expired
- 2004-11-17 WO PCT/GB2004/004831 patent/WO2005048976A2/en not_active Ceased
- 2004-11-17 WO PCT/GB2004/004848 patent/WO2005048977A2/en not_active Ceased
- 2004-11-17 EP EP04798566.8A patent/EP1694292B2/en not_active Expired - Lifetime
- 2004-11-17 MX MXPA06005526A patent/MXPA06005526A/es active IP Right Grant
- 2004-11-17 US US10/522,529 patent/US20060280690A1/en not_active Abandoned
- 2004-11-17 NZ NZ547265A patent/NZ547265A/en not_active IP Right Cessation
- 2004-11-17 CA CA002546227A patent/CA2546227A1/en not_active Abandoned
- 2004-11-17 PL PL04798566T patent/PL1694292T5/pl unknown
- 2004-11-17 JP JP2006540579A patent/JP2007511312A/ja active Pending
- 2004-11-17 SI SI200431254A patent/SI1694292T2/sl unknown
- 2004-11-17 EA EA200600985A patent/EA009362B1/ru not_active IP Right Cessation
- 2004-11-17 DE DE602004022190T patent/DE602004022190D1/de not_active Expired - Lifetime
- 2004-11-17 US US10/522,527 patent/US7731986B2/en not_active Expired - Lifetime
- 2004-11-17 PT PT04798564T patent/PT1701701E/pt unknown
- 2004-11-17 KR KR1020067012055A patent/KR101172081B1/ko not_active Expired - Fee Related
- 2004-11-17 OA OA1200600161A patent/OA13287A/en unknown
- 2004-11-17 AT AT04798564T patent/ATE453379T2/de active
- 2004-11-17 CA CA002546076A patent/CA2546076A1/en not_active Abandoned
- 2004-11-17 CA CA2546232A patent/CA2546232C/en not_active Expired - Lifetime
- 2004-11-17 DK DK04798566.8T patent/DK1694292T4/en active
- 2004-11-17 AU AU2004290957A patent/AU2004290957A1/en not_active Abandoned
- 2004-11-17 ES ES04798564T patent/ES2339117T5/es not_active Expired - Lifetime
- 2004-11-17 US US10/522,525 patent/US20060062736A1/en not_active Abandoned
- 2004-11-17 PT PT04798566T patent/PT1694292E/pt unknown
- 2004-11-17 SI SI200431254T patent/SI1694292T1/sl unknown
- 2004-11-17 KR KR1020067012047A patent/KR20070005551A/ko not_active Withdrawn
- 2004-11-17 CA CA002546108A patent/CA2546108A1/en not_active Abandoned
- 2004-11-17 JP JP2006540586A patent/JP4988353B2/ja not_active Expired - Fee Related
- 2004-11-17 KR KR1020067012051A patent/KR20060130074A/ko not_active Withdrawn
-
2006
- 2006-05-16 IL IL175672A patent/IL175672A/en active IP Right Grant
- 2006-05-16 EC EC2006006574A patent/ECSP066574A/es unknown
- 2006-05-30 MA MA29064A patent/MA31041B1/fr unknown
- 2006-06-19 NO NO20062866A patent/NO20062866L/no not_active Application Discontinuation
-
2009
- 2009-10-22 CY CY20091101097T patent/CY1110513T1/el unknown
-
2010
- 2010-03-29 CY CY20101100292T patent/CY1110621T1/el unknown
- 2010-04-23 US US12/765,980 patent/US8323677B2/en not_active Expired - Fee Related
-
2012
- 2012-11-02 US US13/667,296 patent/US8734833B2/en not_active Expired - Fee Related
-
2014
- 2014-04-09 US US14/248,715 patent/US20140221501A1/en not_active Abandoned
-
2015
- 2015-05-08 US US14/708,096 patent/US10472100B2/en not_active Expired - Lifetime
Patent Citations (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2000072821A1 (en) * | 1999-05-26 | 2000-12-07 | Btg International Limited | Generation of therapeutic microfoam |
| WO2002041872A1 (en) * | 2000-11-24 | 2002-05-30 | Btg International Limited | Generation of therapeutic microfoam |
| WO2004062461A2 (en) * | 2003-01-10 | 2004-07-29 | Btg International Limited | Therapeutic microfoam |
Cited By (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| RU2693344C1 (ru) * | 2018-07-05 | 2019-07-02 | Федеральное Государственное Бюджетное Образовательное Учреждение Высшего Образования "Московский государственный медико-стоматологический университет имени А.И. Евдокимова" Министерства здравоохранения Российской Федерации (ФГБОУ ВО МГМСУ имени А.И. Евдокимова Минздрава России) | Способ склеротерапии микропенной артерио-венозных мальформаций челюстно-лицевой области пациента под ультразвуковым контролем |
| RU2780546C1 (ru) * | 2021-10-22 | 2022-09-27 | Федеральное государственное бюджетное учреждение Национальный медицинский исследовательский центр "Центральный научно-исследовательский институт стоматологии и челюстно-лицевой хирургии" Министерства здравоохранения Российской Федерации | Способ деструкции венозных и лимфовенозных мальформаций путем прошивания, склерозирования и компрессии |
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| EA009362B1 (ru) | Терапевтическая пена | |
| US8048439B2 (en) | Therapeutic foam | |
| EP1890678B1 (en) | Therapeutic sclerosing foam containing xenon | |
| HK1094943B (en) | Therapeutic foam comprising a sclerosing solution and a low quantity of gaseous nitrogen |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| MM4A | Lapse of a eurasian patent due to non-payment of renewal fees within the time limit in the following designated state(s) |
Designated state(s): AM AZ BY KZ KG MD TJ TM |